Entitled to special refunds on medicines for epilepsy (and other convulsive disorders) in those aged 16-24, as % of total population of same age (id: 1812)

Organisation Statistical years: Update frequency:
Social Insurance Institution of Finland (Kela) 1990 - 2011 Once a year

Member of

Data source

Social Insurance Institution of Finland (Kela): Statistics on reimbursement entitlements in respect of medicines

Keywords

  • medicines
  • chronic disease
  • epilepsy
  • entitlement to special refunds

Classifications

Geographical classification
Municipality, sub-region, region, area for the regional state administrative agency, major region, Mainland Finland/Åland, hospital district, university hospital special responsibility area, whole country
Classification by sex
male, female, combined
Age classification
Ages 16-24

Data content

The indicator gives the percentage of people entitled to special refunds (75%) of medicines for epilepsy in the 16-24 age group at the end of the calendar year. The cost of medicines is reimbursed for persons suffering from certain severe chronic diseases either under the Higher (100%) or Lower (75%) Special Refund Category.

Interpretation

The patient is eligible to special refund if the disease is chronic and severe and requires long-term medication. The Social Insurance Institution confirms the diagnosis and the severity of the disease on the basis of a certificate issued by a specialist. The Higher (100%) Special Refund Category includes asthma patients meeting the Social Insurance Institution's criteria concerning the severity of the disease. The indicator fairly adequately describes the prevalence of epilepsy in the young adult population.

Restrictions

Individual level data are confidential. For the sake of privacy protection, no municipality level data with less than 4 cases are published.

Additional information

Legislation

Sickness Insurance Act

Recommendations

The indicator can be used to monitor the attainment of the targets set in the Health 2015 public health programme.

Remarks